Brief: Immunocore And Medison Pharma Partner For Future Commercialization Of Tebentafusp In Canada, Central Eastern Europe, And Israel

Immunocore Holdings

18/10/2021 12:40

Oct 18 (Reuters) - Immunocore Holdings PLC  IMCR.O :
    * IMMUNOCORE AND MEDISON PHARMA PARTNER FOR FUTURE
COMMERCIALIZATION OF TEBENTAFUSP IN CANADA, CENTRAL EASTERN
EUROPE, AND ISRAEL

Source text for Eikon:  ID:nGNX3rqmz 
Further company coverage:  IMCR.O 

 ((Reuters.Briefs@thomsonreuters.com;))